Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Abigail R.
Contact Abigail R., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Imaging xCT with Immuno-PET in Therapy-Resistant Non–Small Cell Lung Cancer
MATERALS AND METHODS Additional methods are provided in the supplemental materials, available at http://jnm.snmjournals.org. Lysine residues on HM30, HM34, and control human IgG1 (BioXcell) were labeled using p-SCN-Bn-deferoxamine (DFO; B-705; Macrocyclics). A previously published 2-step method, consisting of chelator–antibody conjugation and subsequent radiolabeling, was used (Supplemental Fig. 1) (23).
Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography
Abstract Mutations in the NRF2-KEAP1 pathway are common in non-small cell lung cancer (NSCLC) and confer broad-spectrum therapeutic resistance, leading to poor outcomes. The cystine/glutamate antiporter, system xc−, is one of the >200 cytoprotective proteins controlled by NRF2, which can be non-invasively imaged by (S)-4-(3-18F-fluoropropyl)-ʟ-glutamate ([18F]FSPG) positron emission tomography (PET).
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Abigail R.
Contact Abigail R., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack